Access to high cost medicines in Australia: ethical perspectives
about
Identifying priority medicines policy issues for New Zealand: a general inductive study.Patient access schemes in Asia-pacific markets: current experience and future potentialExpanding access to high-cost medicines through the E2 access program in Thailand: effects on utilisation, health outcomes and cost using an interrupted time-series analysis.
P2860
Access to high cost medicines in Australia: ethical perspectives
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Access to high cost medicines in Australia: ethical perspectives
@ast
Access to high cost medicines in Australia: ethical perspectives
@en
type
label
Access to high cost medicines in Australia: ethical perspectives
@ast
Access to high cost medicines in Australia: ethical perspectives
@en
prefLabel
Access to high cost medicines in Australia: ethical perspectives
@ast
Access to high cost medicines in Australia: ethical perspectives
@en
P2093
P2860
P921
P356
P1476
Access to high cost medicines in Australia: ethical perspectives
@en
P2093
Christine Y Lu
Ken Williams
Paul Macneill
P2860
P2888
P356
10.1186/1743-8462-5-4
P50
P577
2008-05-19T00:00:00Z
P5875
P6179
1010365906